SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BBE0B98CB1A7748895C576F5C375B83295A3D0C9700273E1B54DA73FF3F2F01A6A4BC5762CA76C334804573C2903E978>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BBE0B98CB1A7748895C576F5C375B83295A3D0C9700273E1B54DA73FF3F2F01A6A4BC5762CA76C334804573C2903E978
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BBE0B98CB1A7748895C576F5C375B83295A3D0C9700273E1B54DA73FF3F2F01A6A4BC5762CA76C334804573C2903E978
http://www.w3.org/2000/01/rdf-schema#comment
"Calbindin D28k and S100B have a similar interaction site with the lithium-inhibitable enzyme inositol monophosphatase-1: a new drug target site"
xsd:string
http://purl.uniprot.org/uniprot/#_F6E47CC371D99E9EA158E626FC419B0F935402F092025E8C7A79685B985C650440410C9E472FAEB425DA0244BA3C42F8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BBE0B98CB1A7748895C576F5C375B83295A3D0C9700273E1B54DA73FF3F2F01A6A4BC5762CA76C334804573C2903E978
http://purl.uniprot.org/uniprot/A0A0S2Z4C5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BBE0B98CB1A7748895C576F5C375B83295A3D0C9700273E1B54DA73FF3F2F01A6A4BC5762CA76C334804573C2903E978
http://purl.uniprot.org/uniprot/#_A0A0S2Z4C5-mappedCitation-25665147
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BBE0B98CB1A7748895C576F5C375B83295A3D0C9700273E1B54DA73FF3F2F01A6A4BC5762CA76C334804573C2903E978